Condition: Obesity · Weight Loss · Sponsor: American University of Beirut Medical Center
In patients initiating Semaglutide for weight management, the objective is to compare the effect of the Mediterranean diet and the high protein/low carbohydrate (HP/LC) diet CV parameters, namely arterial stiffness, measured by carotid-femoral pulse wave velocity (cfPWV), and visceral adipose tissue, in addition to other metabolic indicators.
This description comes directly from the study's public registry record.
Marlene Chakhtoura, MD, MSc · +9611350000 · mc39@aub.edu.lb
Rachelle El Haber, BSc · +9611350000 · re136@aub.edu.lb
Always discuss trial participation with your own doctor first.
| American University of Beirut - Medical Center | Beirut, Riad El Solh, Lebanon | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04990024